Cure My Disease

Don't miss your cure!

 Log in / Sign up

Olive oil and fish: a recipe for a healthier liver?

NCT ID NCT07786831

Prevention Sponsor: Hochschule Campus Wien (University of Applied Sciences Campus Vienna) Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This trial tests whether following a Mediterranean diet for 12 weeks can reduce fat buildup in the liver of healthy young adults aged 20 to 30. Participants are randomly assigned to either a Mediterranean diet or a standard healthy diet, and liver fat is measured using ultrasound at the start, halfway, and end of the study. The goal is to see if this eating pattern can improve liver health and related metabolic measures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mediterranean diet intervention
What this could lead to
If effective, this diet could offer a simple, non-drug way to protect liver health and prevent fatty liver disease in young people.
What could go wrong
This is a small pilot study, so results may not apply broadly. Diet adherence can vary, and the 12-week period may be too short to see lasting changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 30 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 20 to 30 years * Currently enrolled as a student * Body mass index (BMI) less than or equal to 29 kg/m\^2 * Willingness to attend all three study visits at baseline, Week 6, and Week 12 * Willingness to follow the assigned dietary intervention throughout the 12-week study period * Ability to understand the study information and provide written informed consent Exclusion Criteria: * Known acute or chronic liver disease, including non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD) * Acute hepatitis * History of liver transplantation * Excessive alcohol consumption * Heart failure or ascites * Electronic or implanted medical devices that contraindicate bioelectrical impedance analysis (BIA), such as a cardiac pacemaker * Pregnancy * Regular use of medications other than oral contraceptives, including medications with potential hepatotoxic effects * Extreme dietary patterns or use of dietary supplements that may interfere with study outcomes * Unwillingness to follow the assigned dietary intervention or comply with standardized measurement conditions * Inability to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Liver health are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fatty liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Liver health

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hochschule Campus Wien

    RECRUITING

    Vienna, Austria, 1100, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.